Hypersensitivity: to any of the active substances of PENTAXIM; to any of the excipients; to glutaraldehyde, neomycin, streptomycin, or polymyxin B (used during the manufacturing process and which may be present as traces); to a pertussis vaccine (acellular or "whole cell").
Life-threatening reaction after previous injection of the vaccine or a vaccine containing the same substances.
Vaccination must be postponed in case of fever or acute disease.
Evolving encephalopathy.
Encephalopathy within 7 days of administration of a previous dose of any vaccine containing pertussis antigens ("whole cell" or acellular pertussis vaccines).
Pertussis vaccine should not be administered to individuals with uncontrolled neurologic disorder or uncontrolled epilepsy until treatment for the condition has been established, the condition has stabilized and the benefit clearly outweighs the risk.
Other Services
Country
Account